Stemirna is an RNA technology-based drug development company. It works on mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious diseases, protein defects diseases, and genetic diseases.
Stemirna total Funding
Stemirna latest funding size
Time since last funding
|5 months ago|
|WuXi AppTec, Greenwoods Investment, Sequoia Capital China, Zhangjiang Torch Ventures, Zhuhai Longmen № 3, Jiu Youzhi, Yitai Jiuyou, Fanghua Investment, Junshi Bio, China Merchants Medical, Healthcare Industry Equity Fund|
When was Stemirna founded?
Stemirna was founded in 2016.
Who are Stemirna key executives?
Stemirna's key executives are Hangwen Li, Ming Deng and Zhigang Li.
Who are Stemirna competitors?
Competitors of Stemirna include RNAimmune, Moderna and Mercurna.
Where is Stemirna headquarters?
Stemirna headquarters is located at room 603 - 604, building 2, 1295 Chuanqiao Rd, Pudong Xinqu, Shanghai.
Where are Stemirna offices?
Stemirna has an office in Shanghai.
How many offices does Stemirna have?
Stemirna has 1 office.
Receive alerts for 300+ data fields across thousands of companies